{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:18:49Z","timestamp":1792304329781,"version":"4.4.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1210\/en.2002-220492","type":"journal-article","created":{"date-parts":[[2002,11,23]],"date-time":"2002-11-23T00:26:31Z","timestamp":1038011191000},"page":"4620-4626","source":"Crossref","is-referenced-by-count":45,"title":["Progestin and G Protein-Coupled Receptor 30 Inhibit Mitogen-Activated Protein Kinase Activity in MCF-7 Breast Cancer Cells"],"prefix":"10.1210","volume":"143","author":[{"given":"Tytti M.","family":"Ahola","sequence":"first","affiliation":[{"name":"Department of Cell Biology (T.M.A., N.A., T.M., T.Y.), Medical School, University of Tampere, 33014 Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Alkio","sequence":"additional","affiliation":[{"name":"Department of Cell Biology (T.M.A., N.A., T.M., T.Y.), Medical School, University of Tampere, 33014 Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Manninen","sequence":"additional","affiliation":[{"name":"Department of Cell Biology (T.M.A., N.A., T.M., T.Y.), Medical School, University of Tampere, 33014 Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Ylikomi","sequence":"additional","affiliation":[{"name":"Department of Cell Biology (T.M.A., N.A., T.M., T.Y.), Medical School, University of Tampere, 33014 Tampere, Finland"},{"name":"Department of Clinical Chemistry (T.Y.), Tampere University Hospital, FIN-33521 Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041121305653800_R1","first-page":"1839","article-title":"Using progestins in clinical practice","volume":"62","author":"Apgar","year":"2000","journal-title":"Am Fam Physician"},{"key":"2019041121305653800_R2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2019041121305653800_R3","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121305653800_R4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"2019041121305653800_R5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"2019041121305653800_R6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/bjc.1996.292","article-title":"Serum progesterone and prognosis in operable breast cancer","volume":"73","author":"Mohr","year":"1996","journal-title":"Br J Cancer"},{"key":"2019041121305653800_R7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1470-2045(02)00732-5","article-title":"Hormone-replacement therapy and breast cancer","volume":"3","author":"Marsden","year":"2002","journal-title":"Lancet Oncol"},{"key":"2019041121305653800_R8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ijc.2910480209","article-title":"Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast","volume":"48","author":"Williams","year":"1991","journal-title":"Int J Cancer"},{"key":"2019041121305653800_R9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bjc.1988.185","article-title":"The effect of age and menstrual cycle upon proliferative activity of the normal human breast","volume":"58","author":"Potten","year":"1988","journal-title":"Br J Cancer"},{"key":"2019041121305653800_R10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006482418082","article-title":"Effects of oral contraceptives on breast epithelial proliferation","volume":"65","author":"Isaksson","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"2019041121305653800_R11","first-page":"1333","article-title":"Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice","volume":"11","author":"Mizukami","year":"1991","journal-title":"Anticancer Res"},{"key":"2019041121305653800_R12","first-page":"2880","article-title":"Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231","volume":"7","author":"Lin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2019041121305653800_R13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0960-0760(95)00215-4","article-title":"Effects of two classes of progestogens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121305653800_R14","first-page":"5084","article-title":"Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells","volume":"48","author":"Sutherland","year":"1988","journal-title":"Cancer Res"},{"key":"2019041121305653800_R15","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","article-title":"Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor \u03b1, epidermal growth factor receptor, c-fos, and c-myc genes","volume":"11","author":"Musgrove","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2019041121305653800_R16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(98)00028-4","article-title":"Progestins and breast cancer","volume":"65","author":"Pasqualini","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121305653800_R17","first-page":"395","article-title":"Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA","volume":"5","author":"Lin","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2019041121305653800_R18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0960-0760(95)00216-2","article-title":"Effects of two classes of progestogens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121305653800_R19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041121305653800_R20","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/MCB.18.4.1812","article-title":"Mechanisms of cyclin-dependent kinase inactivation by progestins","volume":"18","author":"Musgrove","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019041121305653800_R21","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1128\/MCB.20.7.2581-2591.2000","article-title":"Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells","volume":"20","author":"Swarbrick","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041121305653800_R22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J"},{"key":"2019041121305653800_R23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/bbrc.1997.6746","article-title":"Rapid activation of MAP kinase by estrogen in the bone cell line","volume":"235","author":"Endoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121305653800_R24","first-page":"6360","article-title":"Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells","volume":"61","author":"Caristi","year":"2001","journal-title":"Cancer Res"},{"key":"2019041121305653800_R25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol Cell"},{"key":"2019041121305653800_R26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"2019041121305653800_R27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6","article-title":"Integrating the MAP kinase signal into the G1 phase cell cycle machinery","volume":"22","author":"Roovers","year":"2000","journal-title":"Bioessays"},{"key":"2019041121305653800_R28","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1074\/jbc.270.25.14843","article-title":"How MAP kinases are regulated","volume":"270","author":"Cobb","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121305653800_R29","first-page":"E769","article-title":"Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin","volume":"272","author":"Yoshitomi","year":"1997","journal-title":"Am J Physiol"},{"key":"2019041121305653800_R30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0014-5793(96)01159-3","article-title":"A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines","volume":"397","author":"Cattaneo","year":"1996","journal-title":"FEBS Lett"},{"key":"2019041121305653800_R31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.032661999","article-title":"Adenovirus-directed expression of Q227L-G \u03b1(s) inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice","volume":"99","author":"Santore","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121305653800_R32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1054\/bjoc.2001.1976","article-title":"Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2","volume":"85","author":"Darmoul","year":"2001","journal-title":"Br J Cancer"},{"key":"2019041121305653800_R33","first-page":"2641","article-title":"The Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B","volume":"61","author":"Montaner","year":"2001","journal-title":"Cancer Res"},{"key":"2019041121305653800_R34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/35010529","article-title":"Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1","volume":"2","author":"Xu","year":"2000","journal-title":"Nat Cell Biol"},{"key":"2019041121305653800_R35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1291\/hypres.22.67","article-title":"Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition","volume":"22","author":"Xoriuchi","year":"1999","journal-title":"Hypertens Res"},{"key":"2019041121305653800_R36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0928-4257(00)00206-0","article-title":"Signal transduction of somatostatin receptors negatively controlling cell proliferation","volume":"94","author":"Ferjoux","year":"2000","journal-title":"J Physiol Paris"},{"key":"2019041121305653800_R37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35079135","article-title":"Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor","volume":"411","author":"Ohtaki","year":"2001","journal-title":"Nature"},{"key":"2019041121305653800_R38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/geno.1997.4972","article-title":"Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer","volume":"45","author":"Carmeci","year":"1997","journal-title":"Genomics"},{"key":"2019041121305653800_R39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/bbrc.1997.6161","article-title":"Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors","volume":"231","author":"Feng","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121305653800_R40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bbrc.1996.1654","article-title":"Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt\u2019s lymphoma and widely distributed in brain and peripheral tissues","volume":"228","author":"Owman","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121305653800_R41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(97)00278-0","article-title":"A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue","volume":"407","author":"Kvingedal","year":"1997","journal-title":"FEBS Lett"},{"key":"2019041121305653800_R42","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1046\/j.1432-1033.2002.02912.x","article-title":"Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells","volume":"269","author":"Ahola","year":"2002","journal-title":"Eur J Biochem"},{"key":"2019041121305653800_R43","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1210\/en.2001-211445","article-title":"G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells","volume":"143","author":"Ahola","year":"2002","journal-title":"Endocrinology"},{"key":"2019041121305653800_R44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2019041121305653800_R45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2019041121305653800_R46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(89)90710-0","article-title":"Quantification of cells cultured on 96-well plates","volume":"182","author":"Kueng","year":"1989","journal-title":"Anal Biochem"},{"key":"2019041121305653800_R47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0303-7207(98)00086-0","article-title":"Progesterone receptor in chicken bursa of Fabricius and thymus: evidence for expression in B-lymphocytes","volume":"141","author":"Pasanen","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121305653800_R48","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","article-title":"A synthetic inhibitor of the mitogen-activated protein kinase cascade","volume":"92","author":"Dudley","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121305653800_R49","doi-asserted-by":"crossref","first-page":"27489","DOI":"10.1074\/jbc.270.46.27489","article-title":"PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.","volume":"270","author":"Alessi","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121305653800_R50","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase","volume":"273","author":"Favata","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041121305653800_R51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.1313186","article-title":"Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes","volume":"255","author":"Posada","year":"1992","journal-title":"Science"},{"key":"2019041121305653800_R52","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/j.1460-2075.1994.tb06489.x","article-title":"Requirement for the MAP kinase kinase\/MAP kinase cascade in Xenopus oocyte maturation","volume":"13","author":"Kosako","year":"1994","journal-title":"EMBO J"},{"key":"2019041121305653800_R53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1083\/jcb.122.3.645","article-title":"Requirement for Raf and MAP kinase function during the meiotic maturation of Xenopus oocytes","volume":"122","author":"Fabian","year":"1993","journal-title":"J Cell Biol"},{"key":"2019041121305653800_R54","doi-asserted-by":"crossref","first-page":"25898","DOI":"10.1074\/jbc.270.43.25898","article-title":"Initiation of Xenopus oocyte maturation by activation of the mitogen-activated protein kinase cascade","volume":"270","author":"Gotoh","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121305653800_R55","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/MCB.21.18.6122-6131.2001","article-title":"Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294","volume":"21","author":"Shen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2019041121305653800_R56","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1073\/pnas.95.5.2648","article-title":"Expression of Q227L-g\u03b1s in MCF-7 human breast cancer cells inhibits tumorigenesis","volume":"95","author":"Chen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121305653800_R57","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"2019041121305653800_R58","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1128\/MCB.18.4.1978","article-title":"pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167","volume":"18","author":"Joel","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019041121305653800_R59","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome","volume":"97","author":"Lange","year":"2000","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/143\/12\/4620\/11128194\/endo4620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:42:44Z","timestamp":1555047764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/143\/12\/4620\/2880217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2002-220492","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]}}}